NEJM:复旦大学联手哈佛大学首度发现卵巢早衰致病基因

2014-03-11 佚名 新华网

6 日,复旦大学和哈佛大学共同领衔的一项合作研究首次在卵巢早衰病人中发现了减数分裂基因中的突变可以导致该病。【原文下载】 该项研究为探索卵巢早衰或卵巢功能不全的发生机理,以及阐明该病的临床高度异质性和遗传病因复杂性开辟了一个新的研究途径。相关假说历经10年终于在小鼠动物模型和卵巢早衰病患中都得到了证实。 卵巢早衰通常是指女性 40 岁之前闭经,伴有高卵泡刺激素和低雌激素水平。该病因复杂,受遗传

6 日,复旦大学和哈佛大学共同领衔的一项合作研究首次在卵巢早衰病人中发现了减数分裂基因中的突变可以导致该病。

该项研究为探索卵巢早衰或卵巢功能不全的发生机理,以及阐明该病的临床高度异质性和遗传病因复杂性开辟了一个新的研究途径。相关假说历经10年终于在小鼠动物模型和卵巢早衰病患中都得到了证实。

卵巢早衰通常是指女性 40 岁之前闭经,伴有高卵泡刺激素和低雌激素水平。该病因复杂,受遗传因素的影响,且临床高度异质。国际医学界认为,目前已发现了数十种基因通过不同的作用机制和致病途径影响卵巢功能。

最近的研究发现,卵巢发育需要若干基因通过多种途径发挥作用,并相互协调,不同基因的突变可能通过累积效应或级联反应导致卵巢功能的完全丧失。这些基因分布于 X 染色体和常染色体,目前,国际医学界对这些基因的认识还远远不够,许多通过动物模型发现的候选基因在人体中的作用还未得到证实。

研究人员表示,该论文的通信作者—复旦大学特聘教授吴柏林,是哈佛大学医学院附属波士顿儿童医院研究员。

美国哈佛大学医学院波斯顿儿童医院学术院长欧拉帕拉特教授认为,复旦大学是基因组学和儿童健康研究领域的重镇,相关成果反映了哈佛大学与复旦大学的愈加紧密的合作关系。

这项合作研究还包括了解放军 105 医院、复旦大学附属儿科医院和复旦大学生物医学研究院等国内数家单位。研究成果“ HFM1基因突变导致隐性遗传卵巢早衰”发表在国际权威科学期刊《新英格兰医学杂志》(The New England Journal of Medicine)上。

原始出处:

Jian Wang, Wenxiang Zhang, Hong Jiang, Bai-Lin Wu. Mutations in HFM1 in Recessive Primary Ovarian Insufficiency. N Engl J Med, March 6, 2014;

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=9642, encodeId=ddc09642fa, content=希望能找到原因,制定好的治疗方案。。用于临床, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xxqo, createdTime=Sun Jun 01 10:51:00 CST 2014, time=2014-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8999, encodeId=9aac8999e7, content=其内容真实性,其网站真实性????, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=woaixc, createdTime=Tue Apr 15 09:58:00 CST 2014, time=2014-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8756, encodeId=0a978e5627, content=找到了疾病的原因,能尽快研究出好的治疗方法吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=woaiziji, createdTime=Sat Mar 29 14:56:00 CST 2014, time=2014-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488492, encodeId=2b5e148849259, content=<a href='/topic/show?id=b569864e51e' target=_blank style='color:#2F92EE;'>#致病基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86475, encryptionId=b569864e51e, topicName=致病基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d1a8427162, createdName=wfang548, createdTime=Thu Mar 13 00:42:00 CST 2014, time=2014-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538431, encodeId=6a46153843181, content=<a href='/topic/show?id=751e42660f1' target=_blank style='color:#2F92EE;'>#复旦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42660, encryptionId=751e42660f1, topicName=复旦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6c312994908, createdName=saikp, createdTime=Thu Mar 13 00:42:00 CST 2014, time=2014-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557404, encodeId=ffd7155e40442, content=<a href='/topic/show?id=7bec398e2e6' target=_blank style='color:#2F92EE;'>#哈佛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39872, encryptionId=7bec398e2e6, topicName=哈佛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c7014916331, createdName=amyloid, createdTime=Thu Mar 13 00:42:00 CST 2014, time=2014-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8291, encodeId=78b2829179, content=Correspondence?, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=129.81.57.125, createdTime=Wed Mar 12 00:13:00 CST 2014, time=2014-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8287, encodeId=68ca828e57, content=希望能指导临床, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=464c98216, createdName=luananhui, createdTime=Tue Mar 11 21:44:00 CST 2014, time=2014-03-11, status=1, ipAttribution=)]
    2014-06-01 xxqo

    希望能找到原因,制定好的治疗方案。。用于临床

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=9642, encodeId=ddc09642fa, content=希望能找到原因,制定好的治疗方案。。用于临床, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xxqo, createdTime=Sun Jun 01 10:51:00 CST 2014, time=2014-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8999, encodeId=9aac8999e7, content=其内容真实性,其网站真实性????, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=woaixc, createdTime=Tue Apr 15 09:58:00 CST 2014, time=2014-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8756, encodeId=0a978e5627, content=找到了疾病的原因,能尽快研究出好的治疗方法吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=woaiziji, createdTime=Sat Mar 29 14:56:00 CST 2014, time=2014-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488492, encodeId=2b5e148849259, content=<a href='/topic/show?id=b569864e51e' target=_blank style='color:#2F92EE;'>#致病基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86475, encryptionId=b569864e51e, topicName=致病基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d1a8427162, createdName=wfang548, createdTime=Thu Mar 13 00:42:00 CST 2014, time=2014-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538431, encodeId=6a46153843181, content=<a href='/topic/show?id=751e42660f1' target=_blank style='color:#2F92EE;'>#复旦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42660, encryptionId=751e42660f1, topicName=复旦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6c312994908, createdName=saikp, createdTime=Thu Mar 13 00:42:00 CST 2014, time=2014-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557404, encodeId=ffd7155e40442, content=<a href='/topic/show?id=7bec398e2e6' target=_blank style='color:#2F92EE;'>#哈佛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39872, encryptionId=7bec398e2e6, topicName=哈佛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c7014916331, createdName=amyloid, createdTime=Thu Mar 13 00:42:00 CST 2014, time=2014-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8291, encodeId=78b2829179, content=Correspondence?, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=129.81.57.125, createdTime=Wed Mar 12 00:13:00 CST 2014, time=2014-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8287, encodeId=68ca828e57, content=希望能指导临床, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=464c98216, createdName=luananhui, createdTime=Tue Mar 11 21:44:00 CST 2014, time=2014-03-11, status=1, ipAttribution=)]
    2014-04-15 woaixc

    其内容真实性,其网站真实性????

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=9642, encodeId=ddc09642fa, content=希望能找到原因,制定好的治疗方案。。用于临床, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xxqo, createdTime=Sun Jun 01 10:51:00 CST 2014, time=2014-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8999, encodeId=9aac8999e7, content=其内容真实性,其网站真实性????, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=woaixc, createdTime=Tue Apr 15 09:58:00 CST 2014, time=2014-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8756, encodeId=0a978e5627, content=找到了疾病的原因,能尽快研究出好的治疗方法吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=woaiziji, createdTime=Sat Mar 29 14:56:00 CST 2014, time=2014-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488492, encodeId=2b5e148849259, content=<a href='/topic/show?id=b569864e51e' target=_blank style='color:#2F92EE;'>#致病基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86475, encryptionId=b569864e51e, topicName=致病基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d1a8427162, createdName=wfang548, createdTime=Thu Mar 13 00:42:00 CST 2014, time=2014-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538431, encodeId=6a46153843181, content=<a href='/topic/show?id=751e42660f1' target=_blank style='color:#2F92EE;'>#复旦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42660, encryptionId=751e42660f1, topicName=复旦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6c312994908, createdName=saikp, createdTime=Thu Mar 13 00:42:00 CST 2014, time=2014-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557404, encodeId=ffd7155e40442, content=<a href='/topic/show?id=7bec398e2e6' target=_blank style='color:#2F92EE;'>#哈佛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39872, encryptionId=7bec398e2e6, topicName=哈佛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c7014916331, createdName=amyloid, createdTime=Thu Mar 13 00:42:00 CST 2014, time=2014-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8291, encodeId=78b2829179, content=Correspondence?, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=129.81.57.125, createdTime=Wed Mar 12 00:13:00 CST 2014, time=2014-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8287, encodeId=68ca828e57, content=希望能指导临床, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=464c98216, createdName=luananhui, createdTime=Tue Mar 11 21:44:00 CST 2014, time=2014-03-11, status=1, ipAttribution=)]
    2014-03-29 woaiziji

    找到了疾病的原因,能尽快研究出好的治疗方法吗

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=9642, encodeId=ddc09642fa, content=希望能找到原因,制定好的治疗方案。。用于临床, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xxqo, createdTime=Sun Jun 01 10:51:00 CST 2014, time=2014-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8999, encodeId=9aac8999e7, content=其内容真实性,其网站真实性????, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=woaixc, createdTime=Tue Apr 15 09:58:00 CST 2014, time=2014-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8756, encodeId=0a978e5627, content=找到了疾病的原因,能尽快研究出好的治疗方法吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=woaiziji, createdTime=Sat Mar 29 14:56:00 CST 2014, time=2014-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488492, encodeId=2b5e148849259, content=<a href='/topic/show?id=b569864e51e' target=_blank style='color:#2F92EE;'>#致病基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86475, encryptionId=b569864e51e, topicName=致病基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d1a8427162, createdName=wfang548, createdTime=Thu Mar 13 00:42:00 CST 2014, time=2014-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538431, encodeId=6a46153843181, content=<a href='/topic/show?id=751e42660f1' target=_blank style='color:#2F92EE;'>#复旦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42660, encryptionId=751e42660f1, topicName=复旦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6c312994908, createdName=saikp, createdTime=Thu Mar 13 00:42:00 CST 2014, time=2014-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557404, encodeId=ffd7155e40442, content=<a href='/topic/show?id=7bec398e2e6' target=_blank style='color:#2F92EE;'>#哈佛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39872, encryptionId=7bec398e2e6, topicName=哈佛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c7014916331, createdName=amyloid, createdTime=Thu Mar 13 00:42:00 CST 2014, time=2014-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8291, encodeId=78b2829179, content=Correspondence?, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=129.81.57.125, createdTime=Wed Mar 12 00:13:00 CST 2014, time=2014-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8287, encodeId=68ca828e57, content=希望能指导临床, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=464c98216, createdName=luananhui, createdTime=Tue Mar 11 21:44:00 CST 2014, time=2014-03-11, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=9642, encodeId=ddc09642fa, content=希望能找到原因,制定好的治疗方案。。用于临床, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xxqo, createdTime=Sun Jun 01 10:51:00 CST 2014, time=2014-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8999, encodeId=9aac8999e7, content=其内容真实性,其网站真实性????, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=woaixc, createdTime=Tue Apr 15 09:58:00 CST 2014, time=2014-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8756, encodeId=0a978e5627, content=找到了疾病的原因,能尽快研究出好的治疗方法吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=woaiziji, createdTime=Sat Mar 29 14:56:00 CST 2014, time=2014-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488492, encodeId=2b5e148849259, content=<a href='/topic/show?id=b569864e51e' target=_blank style='color:#2F92EE;'>#致病基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86475, encryptionId=b569864e51e, topicName=致病基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d1a8427162, createdName=wfang548, createdTime=Thu Mar 13 00:42:00 CST 2014, time=2014-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538431, encodeId=6a46153843181, content=<a href='/topic/show?id=751e42660f1' target=_blank style='color:#2F92EE;'>#复旦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42660, encryptionId=751e42660f1, topicName=复旦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6c312994908, createdName=saikp, createdTime=Thu Mar 13 00:42:00 CST 2014, time=2014-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557404, encodeId=ffd7155e40442, content=<a href='/topic/show?id=7bec398e2e6' target=_blank style='color:#2F92EE;'>#哈佛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39872, encryptionId=7bec398e2e6, topicName=哈佛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c7014916331, createdName=amyloid, createdTime=Thu Mar 13 00:42:00 CST 2014, time=2014-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8291, encodeId=78b2829179, content=Correspondence?, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=129.81.57.125, createdTime=Wed Mar 12 00:13:00 CST 2014, time=2014-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8287, encodeId=68ca828e57, content=希望能指导临床, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=464c98216, createdName=luananhui, createdTime=Tue Mar 11 21:44:00 CST 2014, time=2014-03-11, status=1, ipAttribution=)]
    2014-03-13 saikp
  6. [GetPortalCommentsPageByObjectIdResponse(id=9642, encodeId=ddc09642fa, content=希望能找到原因,制定好的治疗方案。。用于临床, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xxqo, createdTime=Sun Jun 01 10:51:00 CST 2014, time=2014-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8999, encodeId=9aac8999e7, content=其内容真实性,其网站真实性????, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=woaixc, createdTime=Tue Apr 15 09:58:00 CST 2014, time=2014-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8756, encodeId=0a978e5627, content=找到了疾病的原因,能尽快研究出好的治疗方法吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=woaiziji, createdTime=Sat Mar 29 14:56:00 CST 2014, time=2014-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488492, encodeId=2b5e148849259, content=<a href='/topic/show?id=b569864e51e' target=_blank style='color:#2F92EE;'>#致病基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86475, encryptionId=b569864e51e, topicName=致病基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d1a8427162, createdName=wfang548, createdTime=Thu Mar 13 00:42:00 CST 2014, time=2014-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538431, encodeId=6a46153843181, content=<a href='/topic/show?id=751e42660f1' target=_blank style='color:#2F92EE;'>#复旦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42660, encryptionId=751e42660f1, topicName=复旦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6c312994908, createdName=saikp, createdTime=Thu Mar 13 00:42:00 CST 2014, time=2014-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557404, encodeId=ffd7155e40442, content=<a href='/topic/show?id=7bec398e2e6' target=_blank style='color:#2F92EE;'>#哈佛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39872, encryptionId=7bec398e2e6, topicName=哈佛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c7014916331, createdName=amyloid, createdTime=Thu Mar 13 00:42:00 CST 2014, time=2014-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8291, encodeId=78b2829179, content=Correspondence?, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=129.81.57.125, createdTime=Wed Mar 12 00:13:00 CST 2014, time=2014-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8287, encodeId=68ca828e57, content=希望能指导临床, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=464c98216, createdName=luananhui, createdTime=Tue Mar 11 21:44:00 CST 2014, time=2014-03-11, status=1, ipAttribution=)]
    2014-03-13 amyloid
  7. [GetPortalCommentsPageByObjectIdResponse(id=9642, encodeId=ddc09642fa, content=希望能找到原因,制定好的治疗方案。。用于临床, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xxqo, createdTime=Sun Jun 01 10:51:00 CST 2014, time=2014-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8999, encodeId=9aac8999e7, content=其内容真实性,其网站真实性????, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=woaixc, createdTime=Tue Apr 15 09:58:00 CST 2014, time=2014-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8756, encodeId=0a978e5627, content=找到了疾病的原因,能尽快研究出好的治疗方法吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=woaiziji, createdTime=Sat Mar 29 14:56:00 CST 2014, time=2014-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488492, encodeId=2b5e148849259, content=<a href='/topic/show?id=b569864e51e' target=_blank style='color:#2F92EE;'>#致病基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86475, encryptionId=b569864e51e, topicName=致病基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d1a8427162, createdName=wfang548, createdTime=Thu Mar 13 00:42:00 CST 2014, time=2014-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538431, encodeId=6a46153843181, content=<a href='/topic/show?id=751e42660f1' target=_blank style='color:#2F92EE;'>#复旦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42660, encryptionId=751e42660f1, topicName=复旦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6c312994908, createdName=saikp, createdTime=Thu Mar 13 00:42:00 CST 2014, time=2014-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557404, encodeId=ffd7155e40442, content=<a href='/topic/show?id=7bec398e2e6' target=_blank style='color:#2F92EE;'>#哈佛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39872, encryptionId=7bec398e2e6, topicName=哈佛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c7014916331, createdName=amyloid, createdTime=Thu Mar 13 00:42:00 CST 2014, time=2014-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8291, encodeId=78b2829179, content=Correspondence?, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=129.81.57.125, createdTime=Wed Mar 12 00:13:00 CST 2014, time=2014-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8287, encodeId=68ca828e57, content=希望能指导临床, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=464c98216, createdName=luananhui, createdTime=Tue Mar 11 21:44:00 CST 2014, time=2014-03-11, status=1, ipAttribution=)]
    2014-03-12 129.81.57.125

    Correspondence?

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=9642, encodeId=ddc09642fa, content=希望能找到原因,制定好的治疗方案。。用于临床, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xxqo, createdTime=Sun Jun 01 10:51:00 CST 2014, time=2014-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8999, encodeId=9aac8999e7, content=其内容真实性,其网站真实性????, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=woaixc, createdTime=Tue Apr 15 09:58:00 CST 2014, time=2014-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8756, encodeId=0a978e5627, content=找到了疾病的原因,能尽快研究出好的治疗方法吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=woaiziji, createdTime=Sat Mar 29 14:56:00 CST 2014, time=2014-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488492, encodeId=2b5e148849259, content=<a href='/topic/show?id=b569864e51e' target=_blank style='color:#2F92EE;'>#致病基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86475, encryptionId=b569864e51e, topicName=致病基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d1a8427162, createdName=wfang548, createdTime=Thu Mar 13 00:42:00 CST 2014, time=2014-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538431, encodeId=6a46153843181, content=<a href='/topic/show?id=751e42660f1' target=_blank style='color:#2F92EE;'>#复旦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42660, encryptionId=751e42660f1, topicName=复旦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6c312994908, createdName=saikp, createdTime=Thu Mar 13 00:42:00 CST 2014, time=2014-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557404, encodeId=ffd7155e40442, content=<a href='/topic/show?id=7bec398e2e6' target=_blank style='color:#2F92EE;'>#哈佛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39872, encryptionId=7bec398e2e6, topicName=哈佛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c7014916331, createdName=amyloid, createdTime=Thu Mar 13 00:42:00 CST 2014, time=2014-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8291, encodeId=78b2829179, content=Correspondence?, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=129.81.57.125, createdTime=Wed Mar 12 00:13:00 CST 2014, time=2014-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8287, encodeId=68ca828e57, content=希望能指导临床, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=464c98216, createdName=luananhui, createdTime=Tue Mar 11 21:44:00 CST 2014, time=2014-03-11, status=1, ipAttribution=)]
    2014-03-11 luananhui

    希望能指导临床

    0

相关资讯

NASPAG:青少年卵巢皮样囊肿复发率约11%

  美国圣迭戈——在北美儿童与青少年妇科学会(NASPAG)2013年会上,加拿大金斯顿皇后大学的医学生Erin Rogers报告称,在儿童和青少年卵巢皮样囊肿人群中,囊肿切除术后的总复发率约为11%,3%的患者因复发需要接受二次手术。此外,手术方式,即腹腔镜手术或开腹手术,对囊肿复发率并无影响。   Rogers称,皮样囊肿在30岁以下女性良性卵巢肿瘤中约占70%。皮样囊肿通常没有症状,往往是

Sci TM:揭示化疗如何引起女性癌症患者不孕

一项新的研究揭示了化疗如何在女性癌症患者中引起不孕,该研究还发现了一种叫做AS101的药物可在治疗期间使卵巢中的卵子储备免受损害。 卵泡是细胞集簇,其中每个卵泡都含有一个卵母细胞或卵子。每个月,这些卵泡中有少数会开始生长和成熟,它们会经历若干阶段直至每个月有一个卵泡达到完全成熟并排卵。随着妇女年龄的增长,静息状态的卵泡数连同卵巢中的卵子供应量会持续地下降。 众所周知,像化疗和放疗等常见的治疗会

JCEM:大脑和卵巢一样 也能产生和释放雌性激素

最近发表在JCEM杂志的一项研究表明,大脑和卵巢一样,也能产生和释放雌性激素,猕猴下丘脑(大脑中参与调节月经周期和生殖的一部分),可以主动释放雌性激素。该研究结果对人类也有同样意义,因为猕猴的生殖内分泌系统(生成和释放激素)与人类是相同的。研究人员发现,雌二醇(三大自然产生的雌激素之一,主要参与女性生殖)可以在大脑中迅速产生。雌二醇还影响身体的其他功能,包括我们的体重和记忆。尽管科学家们怀疑,大脑

Sci Transl Med:RNA纳米粒子纳米粒子缩小小鼠卵巢肿瘤

通过癌症细胞的基因组测序,科学家们发现肿瘤细胞突变,删除或复制的大部分基因。这是个数据宝库,有助寻求新的药物靶标,但要想及时测试这些基因几乎是不可能的。 为了帮助加快这一进程,麻省理工学院的研究人员已经开发出了RNA纳米粒子,该技术能有助快速筛选新的药物靶标。在他们的第一项老鼠研究中,Dana-Farber癌症研究所和Broad研究院的研究人员发现,靶向ID4的纳米粒子可以缩小卵巢肿瘤。Sang

JCEM:围绝经期骨吸收增加与体重指数呈负相关

为了描述最后一次月经期(FMP)、生殖激素、体重指数(BMI),以及种族相关的骨吸收变化,来自美国波士顿麻省总医院内分泌科的Joel S Finkelstein教授及其团队进行了一项研究,该研究发现在绝经过渡期,在FMP前约2年,卵巢功能开始下降,紧接着骨吸收和随后的骨丢失增加。骨吸收增加的量与BMI成负相关。校正BMI后,种族差异在骨吸收变化中的作用被减弱,但没有消失。BMI的种族差异,以及相应

JCEM:GnRHa治疗期间AMH不能反应卵巢储备功能

促性腺激素释放激素激动剂(GnRHa)被实验性用于保护接受化疗年轻女性癌症患者的生育能力。抗苗勒氏管激素(AMH)是由卵巢颗粒细胞产生,可以作为卵巢储备功能的标志,但是在GnRHa治疗期间这项指标是否有用尚不清楚。为了确定长效GnRHa对AMH水平的影响,来自美国麻省总医院Hadine Joffe教授及其团队进行了一项研究,该研究发现GnRHa治疗期间AMH不是卵巢储备功能的一个可靠指标。该研究结